Delivery Order SPE2DB22D3501-SPE2DB25FWP75
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a delivery order valued at $9,418.24 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This competitively awarded, non-set-aside delivery order is scheduled for completion by August 8, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $50,511.39 for NURTEC ODT 75 mg tablets (8-count packaging) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is listed as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.71 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packaging). This firm fixed price, non-set-aside contract was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $16,075.41 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This competitively awarded, firm fixed-price delivery order is set to be completed by August 6, 2025, and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a branded pharmaceutical product used for migraine treatment, representing one component of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,800.92 for NURTEC ODT 75 mg tablets (8-count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication commonly used within the military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order valued at $9,331.54 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on August 4, 2025, with completion targeted for August 5, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $47,367.48 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. NURTEC ODT is a prescription medication used for the acute treatment of migraine, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $20,968.59 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order to be performed at the contractor's Conshohocken, Pennsylvania location. NURTEC ODT is a prescription medication used for acute migraine treatment, reflecting the federal government's ongoing...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWP75Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,906.04 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. NURTEC ODT is a migraine treatment medication, reflecting the range of pharmaceutical products that AmerisourceBergen supplies through its federal contracting relationships. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 7/28/25 |